In October 2022, Blau Farmacêutica [B3:BLAU3] entered into an agreement to buy Bergamo Laboratory, currently owned by Amgen Brazil. The transaction amount was USD 28M. Founded in 1946, Bergamo is located in Taboão da Serra, São Paulo. Currently, Bergamo has a portfolio of 19 products and about 190 employees. The transaction completion is subject to approval by the competent agencies and compliance with certain preceding conditions.
https://www.moneytimes.com.br/blau-blau3-compra-100-do-laboratorio-bergamo-por-us-28-milhoes/
